Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Bipolar disorder (BPD) is a severe psychiatric condition with limited therapeutic options.
• Mitochondrial dysfunction is increasingly recognized as a potential contributor to BPD pathophysiology.
• Understanding these cellular mechanisms is crucial for developing novel treatments.

Purpose of the Study:

• To review evidence linking mitochondrial dysfunction to bipolar disorder.
• To explore mitochondria as a potential therapeutic target for BPD.
• To highlight the role of mitochondria in energy production, apoptosis, and calcium signaling in BPD.

Main Methods:

• Focused on human studies and reviews examining mitochondrial function in BPD.
• Analyzed evidence from postmortem brain studies, peripheral blood analyses, and neuroimaging.
• Investigated polymorphisms in mitochondria-related genes as risk factors.

Main Results:

• Studies indicate decreased electron transport chain (ETC) activity and increased oxidative stress (OxS) in BPD brains.
• Peripheral blood studies show elevated OxS, calcium dysregulation, and proapoptotic signaling in BPD patients.
• Neuroimaging reveals reduced brain energy levels and pH in individuals with BPD.

Conclusions:

• Mitochondrial dysfunction is a significant factor in BPD.
• Targeting mitochondrial energy metabolism, synaptic plasticity, and cell survival pathways presents a promising strategy.
• Developing novel mood-stabilizing agents focused on mitochondrial function could be effective for BPD treatment.